Company profile
3M CO
NYSE:MMMMedical/Dental Instruments
Drug pipeline (13)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ALKAVERVIR | approved | — | 0 | — |
| CHLOPHEDIANOL HYDROCHLORIDE | approved | — | 0 | — |
| Diethylpropion Hydrochloride | approved | — | 0 | — |
| Epinephrine bitartrate | approved | — | 0 | — |
| Ergoloid Mesylates | approved | — | 0 | — |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02203591 | phase3 | completed | 2014-07-01 | 2015-03-01 | 3M | In Vivo Efficacy Study of Patient Preoperative Preps |
FDA applications (20)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| ANDA 084868 | ANDA | 3M PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 085809 | ANDA | 3M PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 086107 | ANDA | 3M PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 086363 | ANDA | 3M PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 088364 | ANDA | 3M PHARMACEUTICALS INC | ||||
Loading… | ||||||